
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About


Modular Medical Inc (MODD)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: MODD (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $8
1 Year Target Price $8
1 | Strong Buy |
0 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -51.28% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 39.98M USD | Price to earnings Ratio - | 1Y Target Price 8 |
Price to earnings Ratio - | 1Y Target Price 8 | ||
Volume (30-day avg) 1 | Beta -4.95 | 52 Weeks Range 0.63 - 2.65 | Updated Date 08/15/2025 |
52 Weeks Range 0.63 - 2.65 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.51 |
Earnings Date
Report Date 2025-08-11 | When After Market | Estimate -0.1 | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -73.17% | Return on Equity (TTM) -131.58% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 27701324 | Price to Sales(TTM) - |
Enterprise Value 27701324 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA -3.21 | Shares Outstanding 54247400 | Shares Floating 43218894 |
Shares Outstanding 54247400 | Shares Floating 43218894 | ||
Percent Insiders 5.87 | Percent Institutions 40.79 |
Upturn AI SWOT
Modular Medical Inc

Company Overview
History and Background
Modular Medical, Inc. is a medical device company focused on developing and commercializing easy-to-use and affordable diabetes management solutions. Founded relatively recently, it aims to disrupt the market with its innovative technology.
Core Business Areas
- Insulin Patch Pump Development: Development and commercialization of a low-cost, easy-to-use insulin patch pump for diabetes management.
Leadership and Structure
Details on leadership and organizational structure are currently limited and not publicly available.
Top Products and Market Share
Key Offerings
- Modular Medical Insulin Pump: The company's primary product is its planned insulin patch pump. Market share is currently 0% as it is not yet commercially available. Competitors include Insulet (PODD) and Medtronic (MDT), Tandem Diabetes Care (TNDM).
Market Dynamics
Industry Overview
The diabetes device market is a large and growing market, driven by the increasing prevalence of diabetes worldwide. It's characterized by innovation and intense competition.
Positioning
Modular Medical aims to compete by offering a more affordable and user-friendly insulin delivery system. Competitive advantage lies in its potential low cost and simplified design.
Total Addressable Market (TAM)
The TAM for insulin delivery systems is estimated to be in the billions of dollars. Modular Medical's positioning is geared towards capturing a segment of the market focused on cost-effectiveness.
Upturn SWOT Analysis
Strengths
- Innovative product design
- Potential for low-cost manufacturing
- Focus on user-friendliness
Weaknesses
- Lack of established market presence
- Dependence on regulatory approvals
- Limited financial resources
- Product not yet commercially available
Opportunities
- Growing diabetes prevalence
- Increasing demand for affordable devices
- Potential for partnerships with healthcare providers
Threats
- Competition from established players
- Technological advancements by competitors
- Changes in healthcare regulations
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- PODD
- MDT
- TNDM
Competitive Landscape
Modular Medical faces intense competition from established players with significant resources and market share. Its success hinges on its ability to differentiate its product and effectively execute its commercialization strategy.
Growth Trajectory and Initiatives
Historical Growth: No historical growth (early stage).
Future Projections: Future growth depends heavily on successful product launch and market acceptance. Analyst estimates are not widely available due to the company's early stage.
Recent Initiatives: Focus on product development and securing regulatory approvals.
Summary
Modular Medical is an early-stage company with a potentially disruptive insulin patch pump. Its success depends on successfully navigating regulatory hurdles, securing funding, and competing against established players. The company's focus on affordability and ease-of-use is a key advantage, but its lack of market presence and limited resources pose significant risks. The company needs to secure funding and focus on regulatory approvals
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings (when available)
- Industry Reports
- Third-party Financial Data Providers
Disclaimers:
This analysis is based on publicly available information and is not financial advice. The information provided is for informational purposes only and should not be considered a recommendation to buy or sell stock. Market share data is estimated and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Modular Medical Inc
Exchange NASDAQ | Headquaters San Diego, CA, United States | ||
IPO Launch date 2007-01-25 | CEO - | ||
Sector Healthcare | Industry Medical Devices | Full time employees 53 | Website https://www.modularmedical.com |
Full time employees 53 | Website https://www.modularmedical.com |
Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It also offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. Modular Medical, Inc. is headquartered in San Diego, California.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.